Regulation 2019/6 identified innovation in the development of new veterinary medicines as one of the main priority areas, enabling new and innovative veterinary medicines to reach the market more efficiently while maintaining high standards of safety and efficacy. Three years after Regulation 2019/6 coming into effect, the Agency is hosting a second edition dedicated to topic of over two days, the event will include sessions on EU legislative framework for veterinary medicinal products, on the Agency’s support to innovation of veterinary medicines and other interactions to support innovative medicines. The event’s programme will be published at a later video recording of the event, together with the relevant presentations, will be made available on this page after the event.